Reply to Birhan Demirhan, Aysenur Elmali, and Cem Onal’s Letter to the Editor re: Daniela E. Oprea-Lagera, Tessa van Elst, Shafak Aluwini, et al. How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View. Eur Urol Open Sci 2025;75:69–79
Daniela E. Oprea‐Lager(Amsterdam University Medical Centers), Niven Mehra(Royal Marsden NHS Foundation Trust), Tessa van Elst(Radboud University Nijmegen), Shafak Aluwini(Erasmus MC Cancer Institute), Herman Stoevelaar(Barnes-Jewish Hospital)
Cited by 0
Related Papers
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis
|Clinical Cancer Research|2018|111
Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)
|European Urology|2018|110
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
|Annals of the Rheumatic Diseases|2010|105
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
|Radiotherapy and Oncology|2022|98